Pritzker Neuropsychiatric Disorders Research Consortium

The Pritzker Neuropsychiatric Disorders Research Consortium is a collaborative research enterprise by leading academic and scientific institutions including research groups at the University of Michigan, Stanford University, the University of California at Irvine, the University of California at Davis, Cornell University, and the HudsonAlpha Institute. The consortium is focused on discovering the neurobiological and genetic causes of three major psychiatric disorders, major depressive disorder, bipolar disorder and schizophrenia, and identifying biomarkers for better diagnosis and novel targets for treatment.[1][2][3]

References

  1. ^ Gomez, R.G.; Posener, J.A.; Keller, J.; DeBattista, C.; Solvason, B.; Schatzberg, A.F. (Aug 2009). "Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function". Psychoneuroendocrinology 34: 1012–18. PMID 19261389. 
  2. ^ Parker, K.J.; Kenna, H.A.; Zeitzer, J.M.; Keller, J.; Blasey, C.M.; Amico, J.A.; Schatzberg A.F. (Jul 2010). "Preliminary evidence that plasma oxytocin levels are elevated in major depression". Psychiatry Res 182 (2): 359–62. PMID 20494448. 
  3. ^ Potkin,S.G.; Macciardi, F.; Guffanti, G.; Fallon, J.H.; Wang, Q.; Turner, J.A.; Lakatos, A.; Miles, M.F.; Lander, A.; Vawter, M.P.; Xie X.; (Nov 2010). "Identifying gene regulatory networks in schizophrenia". Neuroimage 53 (3): 839–47. PMID 20600988. 

External links